Company Overview of 3-V Biosciences, Inc.
Key Executives for 3-V Biosciences, Inc.
|Merdad V. Parsey M.D., Ph.D.||12 Relationships||Chief Executive Officer, President and Director||--|
|Urs Greber Ph.D.||No Relationships||Co-Founder||--|
|David M. Mott||206 Relationships||Executive Chairman||51|
|Lucas Pelkmans Ph.D.||No Relationships||Co-Founder||--|
|Rekha Hemrajani||No Relationships||Chief Financial Officer and Senior Vice President of Business & Financial Operations||--|
|View More Key Executives|
3-V Biosciences, Inc. Board Members*
|Name||Board Relationships||Primary Company||Age|
|David M. Mott||206 Relationships||Mersana Therapeutics, Inc.||51|
|Merdad V. Parsey M.D., Ph.D.||12 Relationships||3-V Biosciences, Inc.||--|
|Ed Harlow Jr., Ph.D.||12 Relationships||3-V Biosciences, Inc.||--|
|Robert J. Garland M.D.||46 Relationships||New Enterprise Associates||--|
|Joseph D. Puglisi Ph.D.||22 Relationships||PTC Therapeutics, Inc.||--|
3-V Biosciences, Inc. Executive Committees*
|Committee Name||Chairperson||Board Relationships||Members|
|Advisory Board Jr., Ph.D.||Ed Harlow||12 Relationships||6 Executives|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
CEO COMPENSATION IN THIS INDUSTRY
|Total Short Term Compensation|
|Total Value of Options|
INDUSTRY EXECUTIVE CHANGES
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.